NRD
STAA icon

Nebula Research & Development’s STAAR Surgical STAA Stock Holding History

Nebula Research & Development’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,743
Closed -$207K – 1139
2025
Q1 		$207K Sell
11,743
-11,467
-49% -$230K 0.02% 856
2024
Q4 		$564K Buy
23,210
+3,700
+19% +$106K 0.07% 509
2024
Q3 		$725K Buy
+19,510
New +$728K 0.09% 426
2024
Q1 		– Sell
-24,551
Closed -$766K – 988
2023
Q4 		$766K Buy
24,551
+17,713
+259% +$636K 0.23% 121
2023
Q3 		$275K Buy
+6,838
New +$320K 0.14% 301

Other funds holding STAA

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RAM
Resona Asset Management Koto-Ku,tokyo, Japan $20.1B AUM 26.26% 1-Year Est. Return
YC
Yunqi Capital Hong Kong $92.4M AUM 16.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nebula Research & Development's STAA Position: Q2 2025 in Review

Nebula Research & Development sold out of STAAR Surgical (STAA) in Q2 2025, closing a stake of 11,743 shares — an estimated $207K sold.

Nebula Research & Development first reported a position in STAA in Q3 2023 and held it in 5 quarters. The position peaked at $766K in Q4 2023. 170 funds tracked by Wall St. Rank hold STAA as of Q2 2025.

  • Nebula Research & Development reported no remaining STAAR Surgical position as of Q2 2025 after selling out during the quarter.
  • Nebula Research & Development sold 11,743 STAAR Surgical shares in Q2 2025, an estimated $207K.
  • Nebula Research & Development first reported a position in STAAR Surgical in Q3 2023 and held it in 5 quarters.
  • Nebula Research & Development's STAAR Surgical position peaked at $766K in Q4 2023.
  • 170 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2025.

Based on Nebula Research & Development's 13F filing for Q2 2025, filed 14 Aug 2025.